NCT06295809 2026-03-27
INTerpath-007
Merck Sharp & Dohme LLC
Phase 2/3 Completed
Clinical Trials
5 trialsNCT03534947 2025-12-16
SONIB
Melanoma Institute Australia
Phase 2 Completed
NCT05794035 2023-11-30
IMPACTE-01
Assistance Publique - Hôpitaux de Paris
Phase NA Recruiting
NCT00126555 2019-08-30
Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT02061007 2016-05-09
Biomarker Correlates of Hypoxia in Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Withdrawn